The Financials and Materials sectors drove a 1.1% increase in the United Kingdom market over the last week, while the Healthcare sector declined by 4.0%, contributing to an overall market climb of 5.8% in the past year with earnings forecasted to grow by 14% annually. In this dynamic environment, identifying high-growth tech stocks can be particularly rewarding, as these companies often leverage innovation and technological advancements to outperform broader market trends.
Top 10 High Growth Tech Companies In The United Kingdom
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Gaming Realms | 11.57% | 22.07% | ★★★★★☆ |
STV Group | 13.15% | 46.78% | ★★★★★☆ |
Altitude Group | 23.46% | 27.56% | ★★★★★☆ |
YouGov | 14.29% | 29.79% | ★★★★★☆ |
Redcentric | 4.89% | 63.79% | ★★★★★☆ |
Windar Photonics | 67.08% | 130.82% | ★★★★★☆ |
LungLife AI | 100.61% | 100.97% | ★★★★★☆ |
IQGeo Group | 11.49% | 63.61% | ★★★★★☆ |
Beeks Financial Cloud Group | 24.63% | 57.95% | ★★★★★☆ |
Vinanz | 113.60% | 125.86% | ★★★★★☆ |
Click here to see the full list of 46 stocks from our UK High Growth Tech and AI Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Genus plc is an animal genetics company with operations spanning North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia; it has a market cap of £1.30 billion.
Operations: Genus plc generates revenue primarily from its two main segments: Genus ABS (£314.90 million) and Genus PIC (£352.50 million). The company operates across multiple regions, including North America, Latin America, the UK, Europe, the Middle East, Russia, Africa, and Asia.
Genus, a prominent player in the biotech sector, has faced a challenging year with earnings declining by 76.3%, contrasting sharply with the industry average decline of 17.8%. Despite this, Genus’s R&D expenses have been substantial at £47.8M, reflecting their commitment to innovation despite financial hurdles. Forecasts indicate significant growth potential with revenues expected to increase by 4.1% annually and earnings projected to surge by 39.4% per year over the next three years, outpacing the UK market’s expected growth of 14.2%.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Informa plc operates as an international events, digital services, and academic research company in the United Kingdom, Continental Europe, the United States, China, and internationally with a market cap of £11.22 billion.
Operations: Informa generates revenue primarily through its four segments: Informa Tech (£426.70 million), Informa Connect (£630.20 million), Informa Markets (£1.67 billion), and Taylor & Francis (£636.70 million). The company operates across various regions, including the UK, Continental Europe, the US, and China.
Informa’s revenue is projected to grow at 6.7% annually, outpacing the UK market’s 3.7%. Despite a significant one-off loss of £213.5M affecting recent results, earnings are forecast to increase by 21.5% per year, indicating robust future potential. The company has repurchased 41.67 million shares for £338.9M in the first half of 2024, reflecting confidence in its growth trajectory and value proposition within the tech sector.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: The Sage Group plc, together with its subsidiaries, provides technology solutions and services for small and medium businesses in the United States, the United Kingdom, France, and internationally, with a market cap of £10.29 billion.
Operations: Sage Group generates revenue primarily from Europe (£595 million), North America (£1.01 billion), and the United Kingdom & Ireland (£488 million). The company focuses on providing technology solutions and services specifically tailored for small and medium businesses across these regions.
Sage Group’s revenue increased by 9% to £585M in Q3 2024, driven by Sage Business Cloud. The company forecasts a steady annual earnings growth of 15.1%, outpacing the UK market’s 14.2%. Their strategic partnership with VoPay enhances payroll functionalities for SMBs, addressing inefficiencies and manual processes that affect over half of businesses. With R&D expenses at £130M (7.5% of revenue), Sage continues to innovate within the SaaS model, ensuring recurring subscription revenue streams and robust financial health despite high debt levels.
Where To Now?
Looking For Alternative Opportunities?
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com